相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diabetic Peripheral Neuropathy Associated with Cardiovascular Risk Factors and Glucagon-Like Peptide-1 Concentrations Among Newly Diagnosed Patients with Type 2 Diabetes Mellitus
Tuan Dinh Le et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2022)
Obese mice weight loss role on nonalcoholic fatty liver disease and endoplasmic reticulum stress treated by a GLP-1 receptor agonist
Rayane Miranda Pontes-da-Silva et al.
INTERNATIONAL JOURNAL OF OBESITY (2022)
The Effects of Dipeptidyl Peptidase 4 Inhibitors on Renal Function in Patients with Type 2 Diabetes Mellitus
Wan-Chia Hsu et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Analysis of serum lysophosphatidylethanolamine levels in patients with non-alcoholic fatty liver disease by liquid chromatography-tandem mass spectrometry
Yusuke Yamamoto et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2021)
Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease
Anna Faivre et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Adenosine an old player with new possibilities in kidney diseases: Preclinical evidences and clinical perspectives
Sneha Pandey et al.
LIFE SCIENCES (2021)
NAD+ metabolism and its roles in cellular processes during ageing
Anthony J. Covarrubias et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Regulatory Effect of Resveratrol on Inflammation Induced by Lipopolysaccharides via Reprograming Intestinal Microbes and Ameliorating Serum Metabolism Profiles
Sujuan Ding et al.
FRONTIERS IN IMMUNOLOGY (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Emodin Improves Glucose and Lipid Metabolism Disorders in Obese Mice via Activating Brown Adipose Tissue and Inducing Browning of White Adipose Tissue
Long Cheng et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Dual Actions of A2A and A3 Adenosine Receptor Ligand Prevents Obstruction-Induced Kidney Fibrosis in Mice
Eun Seon Pak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model
Tongtong Liu et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-κB signals in OVA-induced asthmatic mice
Yujiao Luo et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2021)
Impaired Nicotinamide Adenine Dinucleotide Biosynthesis in the Kidney of Chronic Kidney Disease
Xinhui Liu et al.
FRONTIERS IN PHYSIOLOGY (2021)
Role of NAD+ in regulating cellular and metabolic signaling pathways
Sara Amjad et al.
MOLECULAR METABOLISM (2021)
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Eugen Javor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes
Skander Mulder et al.
DIABETES OBESITY & METABOLISM (2020)
Semaglutide attenuates excessive exercise-induced myocardial injury through inhibiting oxidative stress and inflammation in rats
Qiang Li et al.
LIFE SCIENCES (2020)
Obesity, Hypertension, and Cardiac Dysfunction Novel Roles of Immunometabolism in Macrophage Activation and Inflammation
Alan J. Mouton et al.
CIRCULATION RESEARCH (2020)
Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet-Induced Obese Mice
Xiaodong Sun et al.
DIABETES (2020)
Liraglutide improves obesity-induced renal injury by alleviating uncoupling of the glomerular VEGF-NO axis in obese mice
Kai Li et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2020)
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease
Karen M. Dwyer et al.
NATURE REVIEWS NEPHROLOGY (2020)
Plasma Lipidomics Reveals Insights into Anti-Obesity Effect of Chrysanthemum morifolium Ramat Leaves and Its Constituent Luteolin in High-Fat Diet-Induced Dyslipidemic Mice
Jong Cheol Shon et al.
NUTRIENTS (2020)
The Association Between Femoral Artery Intima-Media Thickness and Serum Glucagon-Like Peptide-1 Levels Among Newly Diagnosed Patients with Type 2 Diabetes Mellitus
Tuan Dinh Le et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease
Liping Zhang et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide
Maryna Basalay et al.
CARDIOVASCULAR DRUGS AND THERAPY (2019)
Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathways
Joseph Yi Zhou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways
Ying Luo et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity
Kasi C. McPherson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Obesity causes renal mitochondrial dysfunction and energy imbalance and accelerates chronic kidney disease in mice
Ana Andres-Hernando et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus
Muhammad Sajid Hamid Akash et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Cholic Acid Supplementation of a High-Fat Obesogenic Diet Suppresses Hepatic Triacylglycerol Accumulation in Mice via a Fibroblast Growth Factor 21-Dependent Mechanism
Siri M. Ippagunta et al.
JOURNAL OF NUTRITION (2018)
Obesity Pathophysiology and Management
Kishore M. Gadde et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Aldosterone is involved in the pathogenesis of obesity-related glomerulopathy through activation of Wnt/-catenin signaling in podocytes
Jia-Jia Zhu et al.
MOLECULAR MEDICINE REPORTS (2018)
Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model
Liping Zhang et al.
NEUROPEPTIDES (2018)
GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis
Chengshi Wang et al.
PLOS ONE (2018)
High-Fat Diet, Betaine, and Polydextrose Induce Changes in Adipose Tissue Inflammation and Metabolism in C57BL/6J Mice
Kaisa Airaksinen et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways
Gunaj Rakipovski et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Glucagon-like peptide-1 analog prevents obesity-related glomerulopathy by inhibiting excessive autophagy in podocytes
Honglei Guo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase
Niharika Samala et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Urine metabolomics of high-fat diet induced obesity using UHPLC-Q-TOF-MS
Lihui Men et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
In vivo metabolomic interpretation of the anti-obesity effects of hyacinth bean (Dolichos lablab L.) administration in high-fat diet mice
Dong Ho Suh et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
Kidney disease and obesity: epidemiology, mechanisms and treatment
Niels Olsen Saraiva Camara et al.
NATURE REVIEWS NEPHROLOGY (2017)
Health Effects of Overweight and Obesity in 195 Countries
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation
Marta Wlodarska et al.
CELL HOST & MICROBE (2017)
Animal models of metabolic syndrome: a review
Sok Kuan Wong et al.
NUTRITION & METABOLISM (2016)
Calorie-induced ER stress suppresses uroguanylin satiety signaling in diet-induced obesity
G. W. Kim et al.
NUTRITION & DIABETES (2016)
Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression
Hua Chen et al.
REDOX BIOLOGY (2016)
Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy
Jingping Liu et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis
Anne-Emilie Decleves et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
A potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, SKI2852, ameliorates metabolic syndrome in diabetic mice models
Hyunhee Oh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
Jesper Lau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice
Tingting Wei et al.
SCIENTIFIC REPORTS (2015)
Assessment of early renal damage in diabetic rhesus monkeys
Dan Wang et al.
ENDOCRINE (2014)
Direct cardiovascular effects of glucagon like peptide-1
Asfandyar Sheikh
DIABETOLOGY & METABOLIC SYNDROME (2013)
GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy
Mengjie Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
The A2b Adenosine Receptor Modulates Glucose Homeostasis and Obesity
Hillary Johnston-Cox et al.
PLOS ONE (2012)
分享论文
